Controversial research at UW-Madison to make a deadly flu virus more dangerous, halted by the government in 2014, has been approved to start again. The work by campus scientist Yoshihiro Kawaoka involves modifying bird flu viruses such as H5N1 so they can spread among ferrets, an animal model for studying the flu in humans. The […]
About seven years ago, researchers at the US DNA sequencing company Illumina started to notice something odd. A new blood test it ran on 125,000 expectant mothers looking for genetic abnormalities such as Down’s syndrome in their foetuses returned some extremely unexpected signals in 10 cases. Chillingly, it dawned on them that the abnormal DNA they were […]
Bill Kohl, chief operating officer for JangoBio, says this marks a step forward in the company’s journey to bring its anti-aging therapy to market, starting with non-agricultural animals. “Things look promising,” Kohl told WisBusiness.com. “We’re working on refining the application, increasing and improving efficacy, and of course monitoring for safety.” JangoBio’s patent-pending therapy relies on […]
An experimental flu vaccine developed by a Madison company reduced flu virus levels and symptoms in people exposed to a mismatched strain, according to study results released Tuesday. The study by FluGen Inc., founded by UW-Madison scientists Yoshi Kawaoka and Gabriele Neumann, simulated the mismatch that frequently occurs when flu strains circulating in winter don’t […]
Invenra and WARF (Wisconsin Alumni Research Foundation) today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, a cancer that is the third most common childhood cancer, after leukemia and brain tumors. The collaboration will use Invenra’s proprietary SNIPERTM technology to allow for precise […]
Exact Sciences Corp. says it is working on separate diagnostic tests to detect 15 of the deadliest types of cancer, and its ultimate, eventual goal is to create, with its partners at Mayo Clinic, a single, universal blood test for cancer. CEO Kevin Conroy said the Madison company, known for its Cologuard stool-based, home test […]
– Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018 – Nearly 15,000 health care providers ordered their first Cologuard test during the fourth quarter – We expect approximately 94 percent of patients who completed a Cologuard test during the fourth quarter to have no out-of-pocket costs READ FULL STORY
Fujifilm Cellular Dynamics, Inc. (FCDI) plans to build a $21 million facility in Madison to manufacture stem cells for use in developing regenerative medicine drugs — its own drugs and those of other companies. FCDI, formerly Cellular Dynamics International, manufactures human induced pluripotent stem cells (iPSCs), which are skin or blood cells that scientists reprogram […]
Talking the cost of doing business in Wisconsin with Tom Still, President of The WI Technology Council, who says there is reason to be optimistic. Also find out about the WI Governors Business Plan Contest. Great conversation about Wisconsin’s technology economic impact and future opportunities. Click image to watch video:
Stemina Biomarker Discovery’s roots are in stem cells, one of the pillars of Madison’s standing in the bioscience world. After eight years as general counsel and director of business development for the Wisconsin Alumni Research Foundation, or WARF, Beth Donley founded Stemina in 2006 with University of Wisconsin–Madison scientist and pioneer stem cell researcher Dr. […]
